Document Detail


Induction of apoptosis in human leukemia K562 cells by cardiotoxin III.
MedLine Citation:
PMID:  15763081     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Cardiotoxin III (CTX III), a basic polypeptide with 60 amino acid residues isolated from Naja naja atra venom, has been reported to have anticancer activity. CTX III was found to inhibit the growth of K562 cells in a time-and dose-dependent manner with IC50 value of 1.7 microg/ml, and it displayed several features of apoptosis including apoptotic body formation, increase of sub G1 population, DNA fragmentation and poly (ADP-ribose) polymerase (PARP) cleavage. Investigation of the mechanism of CTXIII--induced apoptosis revealed that the treatment of K562 cells with CTX III resulted in the activation of caspase-9, caspase-3 and subsequent cleavage of its substrate PARP and that CTXIII was also associated with an early release of cytochrome c from the mitochondria. These results suggest that CTX III may induce apoptosis through a mitochondria- and caspase-dependent mechanism.
Authors:
Sheng-Huei Yang; Mei-Chin Lu; Ching-Ming Chien; Chia-Houg Tsai; Yu-Jhang Lu; Tzyh-Chyuan Hour; Shinne-Ren Lin
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't     Date:  2005-01-27
Journal Detail:
Title:  Life sciences     Volume:  76     ISSN:  0024-3205     ISO Abbreviation:  Life Sci.     Publication Date:  2005 Apr 
Date Detail:
Created Date:  2005-03-14     Completed Date:  2005-04-18     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0375521     Medline TA:  Life Sci     Country:  England    
Other Details:
Languages:  eng     Pagination:  2513-22     Citation Subset:  IM    
Affiliation:
Faculty of Medicinal and Applied Chemistry, Kaohsiung Medical University, Kaohsiung, Taiwan 807, ROC.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Apoptosis / drug effects*
Blotting, Western
Caspase 3
Caspase 9
Caspases / metabolism
Cobra Cardiotoxin Proteins / toxicity*
Cytochromes c / metabolism
DNA Fragmentation / drug effects
Dose-Response Relationship, Drug
Enzyme Activation / drug effects
Flow Cytometry
Humans
Inhibitory Concentration 50
K562 Cells
Mitochondria / drug effects
Poly(ADP-ribose) Polymerases / metabolism
Time Factors
Chemical
Reg. No./Substance:
0/Cobra Cardiotoxin Proteins; 0/cardiotoxin III, Naja naja atra; 9007-43-6/Cytochromes c; EC 2.4.2.30/Poly(ADP-ribose) Polymerases; EC 3.4.22.-/CASP3 protein, human; EC 3.4.22.-/CASP9 protein, human; EC 3.4.22.-/Caspase 3; EC 3.4.22.-/Caspase 9; EC 3.4.22.-/Caspases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Homocysteine alterations in experimental cholestasis and its subsequent cirrhosis.
Next Document:  Monitoring microbial community in a subsurface soil contaminated with hydrocarbons by quinone profil...